Labiotech walks through Novo Nordisk's 2026 pipeline and the new target it has set for risk-adjusted sales from drugs still in development.
Recap by typeshit. Full story at Labiotech.eu.
ABC News' chief medical correspondent walks through the latest Novo Nordisk GLP-1 medication and what sets it apart from drugs already on the market.
Investseekers shares notes on the upcoming French rollout of the Wegovy pill and where Novo Nordisk might launch it next in Europe.
A short social clip runs through the daily checklist of a GLP-1 routine: injections, water, protein and keeping tabs on progress.
Kumar says month one is less about big drops on the scale and more about setting up habits that help the medication work over time.
Polskie Radio takes up the question of how well oral Ozempic holds up for weight loss. Little detail is given beyond the topic itself.
Hotels are adding fridges for medication, protein-heavy menus and wellness-focused itineraries as more guests travel while on GLP-1 drugs.
Loading…